|
|
Volumn 8, Issue 5, 2001, Pages 955-964
|
|
Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8
|
|
Author keywords
Angiogenesis; Bladder cancer; Gene therapy; IL 8
|
|
Indexed keywords
BETA GALACTOSIDASE;
CD31 ANTIGEN;
ENDOTHELIAL CELL GROWTH FACTOR;
FIBROBLAST GROWTH FACTOR 2;
GELATINASE B;
INTERLEUKIN 8;
LYMPHOKINE;
PRIMER DNA;
VASCULOTROPIN;
VASCULOTROPIN A;
ADENOVIRUS;
ANIMAL;
APOPTOSIS;
ARTICLE;
BAGG ALBINO MOUSE;
BLADDER TUMOR;
CELL CULTURE;
CELL DIVISION;
CHEMISTRY;
DRUG EFFECT;
ENZYME IMMUNOASSAY;
FLUORESCENT ANTIBODY TECHNIQUE;
GENE THERAPY;
GENETICS;
HUMAN;
IN SITU HYBRIDIZATION;
MALE;
METABOLISM;
MOUSE;
NICK END LABELING;
NUCLEIC ACID PROBE;
NUDE MOUSE;
PATHOLOGY;
TRANSITIONAL CELL CARCINOMA;
ADENOVIRIDAE;
ANIMALS;
ANTIGENS, CD31;
ANTISENSE ELEMENTS (GENETICS);
APOPTOSIS;
BETA-GALACTOSIDASE;
CARCINOMA, TRANSITIONAL CELL;
CELL DIVISION;
DNA PRIMERS;
ENDOTHELIAL GROWTH FACTORS;
FIBROBLAST GROWTH FACTOR 2;
FLUORESCENT ANTIBODY TECHNIQUE;
GENE THERAPY;
HUMANS;
IMMUNOENZYME TECHNIQUES;
IN SITU HYBRIDIZATION;
IN SITU NICK-END LABELING;
INTERLEUKIN-8;
LYMPHOKINES;
MALE;
MATRIX METALLOPROTEINASE 9;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
TUMOR CELLS, CULTURED;
URINARY BLADDER NEOPLASMS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0035462626
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.8.5.955 Document Type: Article |
|
Times cited : (24)
|
|
References (2)
|
